|
Q-Pharm’s Phase I clinical trial facility includes:
- Outpatient Area: a 5-bed ward with patient monitoring to all beds
- Inpatient Area: 5 single-bed rooms, each with ensuite, and
equipped with patient monitoring to all beds
- Special Purpose Area: 2-bed room, built to PC3 containment
standards
The outpatient area can also be used for short-term trials, with subjects not requiring a high level of nursing support. These facilities are supported by all ancillary services, including:
- Special procedures room (for biopsies, or minor procedures)
- Doctors’ consulting rooms
- Clinical data management areas
- Subjects’ lounge
- Catering facilities
- Secure well appointed pharmacy
- PC2 Clinic Laboratory
Bioequivalence and pharmacokinetics studies are conducted in the Mervyn Eadie Clinic which is a modern, purpose designed 36-bed open-plan ward.
This facility is built to a high standard, complies fully with all applicable state regulations, and provides comfortable accommodation for 36 subjects.
The ward has synchronized digital clocks, comfortable recreation areas and a laboratory for processing and storing biological samples.
Q-Pharm’s drug analysis laboratory has an
excellent equipment base for chromatographic
assays.
The laboratory is equipped with two HPLC/MS-MS’s, a GC/MS, and six HPLC’s, with a full range of detector options. Q-Pharm also has access to other analytical techniques.
The laboratory is able to undertake the analysis of various clinical samples, but most assays are validated for plasma or urine.
The laboratory holds NATA accreditation as a Medical Testing Laboratory which recognises compliance with ISO/IEC 17025/1999.
Q-Pharm’s drug analysis laboratory has extensive experience with a wide-variety of pharmaceutical products, and is also able to undertake the development and validation of new analytical methods, as required.
» Return to top of page
|
